Total Payments
$582.12
2024 Payments
$24.43
Companies
8
Transactions
18
Medicare Patients
3,974
Medicare Billing
$361,719
Payment Breakdown by Category
Food & Beverage$528.12 (90.7%)
Education$54.00 (9.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $528.12 | 15 | 90.7% |
| Education | $54.00 | 3 | 9.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $143.52 | 7 | $0 (2024) |
| PALETTE LIFE SCIENCES, INC. | $120.71 | 1 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $115.27 | 2 | $0 (2017) |
| Boston Scientific Corporation | $79.07 | 1 | $0 (2018) |
| Astellas Pharma US Inc | $57.87 | 3 | $0 (2017) |
| Mission Pharmacal Company | $33.44 | 2 | $0 (2017) |
| KARL STORZ Endoscopy-America | $19.26 | 1 | $0 (2018) |
| NxThera, Inc. | $12.98 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24.43 | 1 | ABBVIE INC. ($24.43) |
| 2023 | $156.04 | 3 | PALETTE LIFE SCIENCES, INC. ($120.71) |
| 2022 | $40.50 | 2 | ABBVIE INC. ($40.50) |
| 2018 | $98.33 | 2 | Boston Scientific Corporation ($79.07) |
| 2017 | $262.82 | 10 | Bayer HealthCare Pharmaceuticals Inc. ($115.27) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/27/2023 | PALETTE LIFE SCIENCES, INC. | — | Food and Beverage | In-kind items and services | $120.71 | General |
| 06/01/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/05/2023 | ABBVIE INC. | LUPRON DEPOT (Drug) | Education | In-kind items and services | $13.50 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/25/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Education | In-kind items and services | $20.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/30/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Education | In-kind items and services | $20.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/24/2018 | Boston Scientific Corporation | GENERAL KIDNEY STONE DISEASE (Device) | Food and Beverage | In-kind items and services | $79.07 | General |
| Category: KIDNEY STONE DISEASE | ||||||
| 02/02/2018 | KARL STORZ Endoscopy-America | RESECTOSCOPE SHEATH ONLY, 26 FR. (Device) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: UROLOGY | ||||||
| 08/09/2017 | AbbVie, Inc. | Androgel (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Endocrinology | ||||||
| 07/12/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $86.70 | General |
| Category: Oncology | ||||||
| 07/12/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: Oncology | ||||||
| 06/30/2017 | NxThera, Inc. | Rezum (Device) | Food and Beverage | Cash or cash equivalent | $12.98 | General |
| Category: Urology | ||||||
| 06/23/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Xtandi | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Urology | ||||||
| 03/31/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Xtandi | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Urology | ||||||
| 03/30/2017 | Mission Pharmacal Company | Uribel (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Analgesic, antispasmodic & antiseptic (urinary) | ||||||
| 03/18/2017 | Mission Pharmacal Company | Uribel (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Analgesic, antispasmodic & antiseptic (urinary) | ||||||
| 01/20/2017 | AbbVie, Inc. | Lupron (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Endocrinology | ||||||
| 01/06/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Xtandi, Vesicare | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,035 | 1,478 | $673,300 | $98,345 |
| 2022 | 14 | 1,038 | 1,420 | $694,721 | $93,579 |
| 2021 | 16 | 1,039 | 1,373 | $909,588 | $101,164 |
| 2020 | 12 | 862 | 1,121 | $438,486 | $68,632 |
Total Patients
3,974
Total Services
5,392
Medicare Billing
$361,719
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 415 | 706 | $345,940 | $60,589 | 17.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 89 | 90 | $64,800 | $10,543 | 16.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 65 | 91 | $45,500 | $7,920 | 17.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 23 | 33 | $56,430 | $5,599 | 9.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 78 | $25,740 | $4,584 | 17.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 31 | 32 | $18,880 | $3,101 | 16.4% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 17 | 22 | $52,780 | $2,504 | 4.7% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 13 | 29 | $24,215 | $1,244 | 5.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 132 | 167 | $22,545 | $1,222 | 5.4% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 56 | 66 | $11,550 | $613.45 | 5.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 77 | 108 | $3,240 | $237.60 | 7.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 47 | 56 | $1,680 | $187.55 | 11.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 324 | 514 | $239,010 | $44,258 | 18.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 109 | 109 | $74,883 | $12,030 | 16.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 175 | 215 | $67,295 | $11,726 | 17.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 58 | 81 | $38,880 | $6,237 | 16.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 26 | 31 | $50,840 | $5,088 | 10.0% |
| 51705 | Simple change of bladder tube | Office | 2022 | 12 | 48 | $40,320 | $3,253 | 8.1% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 18 | 18 | $29,520 | $3,041 | 10.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 21 | 22 | $12,655 | $2,226 | 17.6% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 13 | 16 | $81,800 | $2,004 | 2.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 20 | 20 | $24,040 | $1,750 | 7.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 117 | 156 | $20,904 | $1,122 | 5.4% |
| 51741 | Electronic assessment of bladder emptying | Office | 2022 | 50 | 58 | $10,614 | $529.32 | 5.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 76 | 113 | $3,390 | $249.68 | 7.4% |
About Dr. Robert Hartman, M.D
Dr. Robert Hartman, M.D is a Urology healthcare provider based in Kenosha, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2010. The National Provider Identifier (NPI) number assigned to this provider is 1730404385.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Hartman, M.D has received a total of $582.12 in payments from pharmaceutical and medical device companies, with $24.43 received in 2024. These payments were reported across 18 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($528.12).
As a Medicare-enrolled provider, Hartman has provided services to 3,974 Medicare beneficiaries, totaling 5,392 services with total Medicare billing of $361,719. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Kenosha, WI
- Active Since 04/06/2010
- Last Updated 11/13/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1730404385
Products in Payments
- Xofigo (Drug) $115.27
- GENERAL KIDNEY STONE DISEASE (Device) $79.07
- Myrbetriq (Drug) $57.87
- LUPRON DEPOT (Drug) $54.00
- BOTOX (Biological) $46.26
- Uribel (Drug) $33.44
- Lupron (Drug) $21.83
- Androgel (Drug) $21.43
- RESECTOSCOPE SHEATH ONLY, 26 FR. (Device) $19.26
- Rezum (Device) $12.98
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.